Yamamoto, Hirona
Lee-Okada, Hyeon-Cheol https://orcid.org/0000-0002-5493-8112
Ikeda, Masashi https://orcid.org/0000-0001-6237-2449
Nakamura, Takumi https://orcid.org/0000-0002-5611-6534
Saito, Takeo
Takata, Atsushi https://orcid.org/0000-0002-0928-4586
Yokomizo, Takehiko
Iwata, Nakao https://orcid.org/0000-0003-3189-6076
Kato, Tadafumi https://orcid.org/0000-0001-7856-3952
Kasahara, Takaoki https://orcid.org/0000-0002-0953-5146
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP20dm017097, JP22wm0425008, JP22wm0425008, JP16dm0107098, JP20dm017097, JP22wm0425008)
Article History
Received: 25 March 2022
Revised: 26 January 2023
Accepted: 30 January 2023
First Online: 21 February 2023
Competing interests
: NI has received research support or speakers’ honoraria from Jansen, Takeda, Sumitomo Dainippon Pharma, and Otsuka. T Kat has received a research grant and personal fees from Sumitomo Dainippon Pharma outside of this work. The other authors declare that they have no conflict of interest.